Frontlight ResearchEarly access
Trial site
Velocity Clinical Research, Meridian
- 4closed trials
The trials here
What the 4 trials at this site are about, from their registry records.
- Conditions
- Alzheimer disease2 trials
- Mild cognitive impairment2 trials
- Asthma1 trial
- Phase
- Phase 32 trials
- Phase 21 trial
- Phase 2/31 trial
- Status
- Completed4 trials
- Lead sponsor
- Novo Nordisk A/S2 trials
- Neurocentria, Inc.1 trial
- Upstream Bio Inc.1 trial
Closed trials
Completed
Completed
Study to Evaluate NRCT-101SR in Adult Attention Deficit Hyperactivity Disorder (ADHD)
Completed
A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE Plus)
Completed
A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE)
Site data: ClinicalTrials.govUpdated 15 Nov 2026